Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University
About this trial
This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.
Eligibility criteria
Qualifiers
Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease.
Patients must have the ability to understand and willingness to provide verbal consent.
Participants must speak English, Spanish, Chinese, or Vietnamese.
Disqualifiers
Inability to consent to the study
Plans to change oncologist within 12 months
Employed by the practice site
Patients who anticipate moving from the area within 12 months
Trial design
Treatments tested in this trial
- Receive technology-based supportive cancer care
- Receive redesigned team-based supportive cancer care
Treatment groups
2,996 Participants
are divided into 2 treatment groupsLocations
17University of Alabama at Birmingham35294, BirminghamAlabama, United States
University of South Alabama36688, MobileAlabama, United States
Beckman Research Institute of City of Hope91010, DuarteCalifornia, United States
VA Medical Center, Fresno93703, FresnoCalifornia, United States
Sponsors and collaborators
Stanford University
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator
Source ClinicalTrials.gov